Mandatory notification of trade and disclosure of large shareholding
Gentian Diagnostics ASA (GENT) · publisert 2021-08-25 16:38 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Vatne Equity AS nærstående | – | acquisition | 100 000 | 67,2174 NOK | 2021-08-25 | NO0010748866 | XOSL | llm |
Vedlegg
- GDASA - KRT-1500_Runar Vatne.pdf (tekst hentet ut)
Meldingstekst
Vatne Equity AS, a closely related party of Runar Vatne, Board Member of Gentian Diagnostics ASA, has today purchased 100,000 shares in Gentian Diagnostics ASA at a price of NOK 67.2174 per share. After the transaction Vatne Equity AS and closely related parties of Runar Vatne owns 2,337,224 shares Gentian Diagnostics ASA corresponding to 15.17% of the outstanding shares and voting rights.
This information is subject to the disclosure requirements pursuant to MAR and Section 5-12 of the Norwegian Securities Trading Act and the Norwegian Securities Trading Act 4-2 as regards to the disclosure of large shareholding.